Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Renalytix Receives Written Notification From Nasdaq On August 23, 2024 That Following The Presentation Of Its Operating And Financing Plan, The Co Has Been Granted An Extension Until October 25, 2024 To Regain Compliance With The Minimum Bid Price Requirement And Other Applicable Nasdaq Listing Requirements

Author: Benzinga Newsdesk | August 27, 2024 09:44am

- SEC Filing

Posted In: RNLX